Successful symptomatic management of a patient with Menetrier's disease with long-term antibiotic treatment

Digestion

Volumn 60, Issue 4, 1999, Pages 358-362

  Raderer, Markus ^a   Oberhuber, Georg ^b   Templ, Eva ^b   Wagner, Ludwig ^b   Pötzi, Regina ^b   Wrba, Friedrich ^b   Hejna, Michael ^b   Base, Wolfgang ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Antibiotic treatment; Helicobacter pylori; Menetrier's disease

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; CLARITHROMYCIN; GASTRIN; LANSOPRAZOLE; METRONIDAZOLE;

AGED; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MENETRIER DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS, HYPERTROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; OMEPRAZOLE;

EID: 0032971212     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007683     Document Type: Article

References (27)

1. Lewandronowski KL, Compton CC: The pathology of gastric cancer and conditions predisposing to gastric cancer, in Rustgi AD (ed): Gastrointestinal Cancers: Biology, Diagnosis, and Therapy. Philadelphia, Lippincott-Raven, 1995, pp 217-242.
2. Dayal Y, DeLellis RA: The gastrointestinal tract; in Cotran R, Kumar V, Robbins S (eds): Pathologic Basis of Disease, ed 4. Philadelphia, Saunders, 1989, pp 827-910.
3. Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G: Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Ménétrier Study Group. Scand J Gastroenterol Suppl 1992;194: 1-7.
4. Sferra TJ, Pawel BR, Qualman SJ, Li BU: Ménétrier disease of childhood: Role of cytomegalovirus and transforming growth factor alpha. J Pediatr 1996;128:213-219.
5. Roussel M, Dupont C, Sidibe T, André C, Barbet P, Badoual J: Gastrite hypertrophique bénigne associée à une infection à cytomégalovirus. Arch Fr Pédiatr 1990;47:271-273.
6. Morrison S, Dahms BB, Hoffenberg E, Czinn SJ: Enlarged gastric folds in association with Campylobacter pylori gastritis. Radiology 1989;171:819-821.
7. Bradburn DM, Redwood NF, Venables CW, Gunn A: Medical therapy of Ménétrier's disease with omeprazole. Digestion 1992;52:204-208.
8. 2-antagonists. Am J Med 1987;82:796-802.
9. Mattig H, Mahnke W: Lokalisierter Morbus Ménétrier und Magenkarzinom. Dtsch Z Verdau Stoffwechselkr 1984;44:67-76.
10. Celik C, Ettinger D, Satchidanand S: Massive bleeding in hypertrophic gastropathy (Ménétrier's disease) due to arterio-venous malformation. J Med 1984;15:65-73.
11. Kovacs AA, Churchill MA, Wood D, Mascola L, Zaia JA: Molecular and epidemiologic evaluations of a cluster of cases of Ménétrier's disease associated with cytomegalovirus. Pediatr Infect Dis J 1993;12:1011-1014.
12. Bayerdörffer E, Ritter MM, Hatz R, Brooks W, Stolte M: Ménétrier's disease and Helicobacter pylori (letter). N Engl J Med 1993;329:60.
13. Bayerdörffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M: Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori - Is Helicobacter pylori a pathogenetic factor in Ménétrier's disease? Gut 1994;35:701-704.
14. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 1994;89:116-128.
15. Parsonnet J, Friedman GD, Vandersteen DP: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-1131.
16. EUROGAST Study Group: An association between Helicobacter pylori infection and gastric cancer: An international study. Lancet 1993; 341:1359-1362.
17. Wotherspoon AC, Ortiz-Hidalgo C, Falzon ME, Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.
18. Hussell T, Isaacson PG, Crabtree JE, Spencer J: Cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-574.
19. Nightingale TE, Gruber J: Helicobacter and human cancer. J Natl Cancer Inst 1994;86: 1505-1509.
20. Raderer M, Wrba F, Kornek GV, Maca T, Koller D, Weinlaender G, Hejna M, Scheithauer W: Association between Helicobacter pylori infection and pancreatic cancer? Oncology 1998;55:16-19.
21. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF: Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci 1991; 36:142-145.
22. Herz R, Lombardi E, Wipping F, Stolte M: Helicobacter pylori assoziierte Riesenfaltengastritis. Imitation eines Morbus Ménétrier. Fortschr Med 1992;110:37-40.
23. Wolber RA, Owen DA, Anderson FH, Freeman HJ: Lymphocytic gastritis and giant gastric folds associated with gastrointestinal protein loss. Mod Pathol 1991;4:13-15.
24. Mosnier JF, Flejou JF, Amouyal G, Gayet B, Molas G, Henin D, Potet F: Hypertrophic gastropathy with gastric adenocarcinoma: Ménétrier's disease and lymphocytic gastritis? Gut 1991;32:1565-1567.
25. Talley NJ, Kost L, Haddad A, Zinsmeister AR: Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992;30:3146-3150.
26. Chaussade S, Micholoulos S, Sogni P, Guerre J, Couturier D: Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves. Dig Dis Sci 1994;39:381-384.
27. Bjomsson ES, Abrahamsson H: Comparison between physiologic and erythromycin-induced interdigestive motility. Scand J Gastroenterol 1995;30:139-145.